HumaQRanaMD

PubMed

• Germline and Somatic Fumarate Hydratase Testing in Atypical Uterine Leiomyomata.
  Lindsay M Kipnis, Katelyn M Breen, Diane R Koeller, Alison Schwartz Levine, Zelei Yang, Hyeji Jun, Nabihah Tayob, Samantha M Stokes, Connor P Hayes, Arezou A Ghazani, ...> ;Cancer Prevention Research. 2024 Apr 18
• Advancing Precision Oncology in Hereditary Paraganglioma-Pheochromocytoma Syndromes: Integrated Interpretation and Data Sharing of the Germline and Tumor Genomes.
  Huma Q Rana, Diane R Koeller, McKenzie Walker, Busra Unal, Alison Schwartz Levine, Anu Chittenden, Raymond A Isidro, Connor P Hayes, Monica D Manam, Ryan M Buehler, Da...> ;Cancers. 2024 Feb 26
• Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients.
  Nihat B Agaoglu, Busra Unal, Connor P Hayes, McKenzie Walker, Ozden Hatirnaz Ng, Levent Doganay, Nisan D Can, Huma Q Rana, Arezou A Ghazani> ;Cancer Medicine. 2024 Feb 1
• Racial differences in knowledge, attitudes, and sources of information about germline cancer genetic testing in the U.S.A.: An analysis of the health information Natio...
  Khalid Y Alkhatib, Dejan K Filipas, Nicola Frego, Mara Koelker, Stuart R Lipsitz, Phillip M Pierorazio, Tim Rebbeck, Kerry Kilbridge, Adam S Kibel, Quoc-Dien Trinh, Hu...> ;Preventive Medicine. 2024 Jan 1
• Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.
  Emilia M Pinto, Cintia Fridman, Bonald C Figueiredo, Hector Salvador, Manuel R Teixeira, Carla Pinto, Manuela Pinheiro, Christian P Kratz, Cinzia Lavarino, Edith A M F...> ;HGG Advances. 2024 Jan 11
• Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
  Huma Q Rana, Jill E Stopfer, Michelle Weitz, Lindsay Kipnis, Diane R Koeller, Samantha Culver, Joanna Mercado, Rebecca Sue Gelman, Meghan Underhill-Blazey, Bradley A M...> ;JCO Oncology Practice. 2023 Nov 1
• Right-Sizing Models of Genetic Cancer Predisposition Testing.
  Huma Q Rana, Judy E Garber> ;JAMA Oncology. 2023 Nov 1
• Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception.
  Brittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, Carrie Horton, Parichehr Hemyari, Holly LaDuca, Judy E Garber, Rochelle Scheib, Huma Q Rana> ;Breast Cancer Research and Treatment. 2023 Jul 1
• 1 citations
  Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
  Brittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, Carrie Horton, Parichehr Hemyari, Holly LaDuca, Judy E Garber, Rochelle Scheib, Huma Q Rana> ;Breast Cancer Research and Treatment. 2023 Jul 1
• 1 citations
  Racial Differences in Germline Genetic Testing for Prostate Cancer: A Systematic Review.
  Logan G Briggs, Grant L Steele, Zhiyu Jason Qian, Sara Subbana, Khalid Y Alkhatib, Bjoern J Langbein, David-Dan Nguyen, Jacqueline Cellini, Kerry Kilbridge, Adam S Kib...> ;JCO Oncology Practice. 2023 May 1
• Development and evaluation of INTGRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndrome.
  Raymond A Isidro, Anu Chittenden, McKenzie Walker, Alison Schwartz, Diane R Koeller, Connor P Hayes, Busra Unal, Monica Devi Manam, Ryan M Buehler, Danielle K Manning,...> ;Frontiers in Oncology. 2023 Jan 1
• 1 citations
  Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family.
  Nihat Bugra Agaoglu, Ozden Hatirnaz Ng, Busra Unal, Ozlem Akgun Dogan, Ufuk Amanvermez, Jale Yildiz, Levent Doganay, Arezou A Ghazani, Huma Q Rana> ;Cancer Genetics. 2022 Nov 1
• 20 citations
  Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2.
  Brittany L Bychkovsky, Nihat B Agaoglu, Carolyn Horton, Jing Zhou, Amal Yussuf, Parichehr Hemyari, Marcy E Richardson, Colin Young, Holly LaDuca, Deborah L McGuinness,...> ;JAMA Oncology. 2022 Nov 1
• 13 citations
  Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer.
  Sarah M Nielsen, Sara L Bristow, Judy E Garber, Heather Hampel, Huma Q Rana, N Jewel Samadder, Neal D Shore, Robert L Nussbaum, Esplin, E. D., Edward D Esplin> ;JCO Precision Oncology. 2022 Sep 1
• 7 citations
  Call for action: expanding global access to hereditary cancer genetic testing.
  Brittany Bychkovsky, Huma Q Rana, Foluso Ademuyiwa, Jennifer Plichta, Karen Anderson, Angélica Nogueira-Rodrigues, Cesar A Santa-Maria, Lan G Coffman, Carol Marquez, A...> ;The Lancet. Oncology. 2022 Sep 1
• 1 citations
  Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes.
  Matthew Mossanen, Amin H Nassar, Samantha M Stokes, Nieves Martinez-Chanza, Vivek Kumar, Pier Vitale Nuzzo, David J Kwiatkowski, Judy E Garber, Catherine Curran, Dory ...> ;Clinical Genitourinary Cancer. 2022 Dec 1
• Impact of Genetic Counseling on Patient-Reported Electronic Cancer Family History Collection.
  Rebecca A Vanderwall, Alison Schwartz, Lindsay Kipnis, Catherine M Skefos, Samantha M Stokes, Nizar Bhulani, Michelle Weitz, Rebecca Gelman, Judy E Garber, Huma Q Rana> ;Journal of the National Comprehensive Cancer Network. 2022 Aug 1
• 3 citations
  Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.
  Jacob E Berchuck, Daniel Boiarsky, Rebecca Silver, Rajitha Sunkara, Heather M McClure, Harrison K Tsai, Stephanie Siegmund, Alok K Tewari, Jonathan A Nowak, Neal I Lin...> ;JCO Precision Oncology. 2022 Aug 1
• 2 citations
  Vulvar Melanoma in association with germline MITF p.E318K variant.
  Diane R Koeller, Alison Schwartz, Mia S DeSimone, Huma Q Rana, Vanesa Rojas-Rudilla, Eleanor Russell-Goldman, Alvaro C Laga, Neal I Lindeman, Judy E Garber, Arezou A G...> ;Cancer Genetics. 2022 Apr 1
• 6 citations
  Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
  Brittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, Carrie Horton, Marcy Richardson, Holly LaDuca, Judy E Garber, Huma Q Rana> ;Cancer. 2022 Mar 15
• 13 citations
  CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
  Elio Adib, Talal El Zarif, Amin H Nassar, Elie W Akl, Sarah Abou Alaiwi, Tarek H Mouhieddine, Kathryn Hatchell, Sarah M Nielsen, Huma Q Rana, Toni K Choueiri, David J ...> ;British Journal of Cancer. 2022 Mar 1
• 3 citations
  An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes.
  Alison Schwartz, Danielle K Manning, Diane R Koeller, Anu Chittenden, Raymond A Isidro, Connor P Hayes, Feruza Abraamyan, Monica Devi Manam, Meaghan Dwan, Justine A Ba...> ;Frontiers in Oncology. 2022 Jan 1
• 3 citations
  An optimized protocol for evaluating pathogenicity ofgermline variants in patients suspected with von Hippel-Lindau syndrome: Using somatic genome to inform the role o...
  Diane R Koeller, Danielle K Manning, Alison Schwartz, Anu Chittenden, Connor P Hayes, Feruza Abraamyan, Huma Q Rana, Neal I Lindeman, Judy E Garber, Arezou A Ghazani> ;Methodsx. 2022 Jan 1
• 4 citations
  Assessment of genomic alterations in non-syndromic von Hippel-Lindau: Insight from integrating somatic and germline next generation sequencing genomic data
  Danielle K. Manning, Priyanka Shivdasani, Diane R. Koeller, Alison Schwartz, Huma Q. Rana, Judy Garber, Neal I. Lindeman, Arezou A. Ghazani> ;Data in Brief. 2021 Dec 1
• 5 citations
  Evaluation of TP53 Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic TP53 Variants
  Alison Schwartz, Sophie Hyman, Samantha Stokes, Danielle Castillo, Nadine Tung, Jeffrey N. Weitzel, Huma Q. Rana, Judy Garber> ;JCO Precision Oncology. 2021 Nov 3
• Join now to see all